TITLE

Promoting bone health: Focus on postmenopausal women and patients receiving systemic therapy for breast or prostate cancer

PUB. DATE
April 2010
SOURCE
American Journal of Health-System Pharmacy;Apr2010 Supplement 3, Vol. 67, pS31
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
A quiz concerning osteoporosis and fractures in breast and prostate cancer patients is presented.
ACCESSION #
48911468

 

Related Articles

  • Yearly MRI worthwhile in women with familial breast cancer risk?  // PharmacoEconomics & Outcomes News;9/7/2013, Issue 686, p5 

    The article reports that a Dutch study has found that adding yearly magnetic resonance imaging (MRI) to the screening schedule for women with familial risk for breast cancer can improve survival but is expensive, particularly for young women.

  • Tamoxifen-treated women at risk for oesophageal or gastric cancer?  // Reactions Weekly;9/2/2006, Issue 1117, p3 

    The article discusses research being done on Tamoxifen exposure and risk of oesophageal and gastric adenocarcinoma in breast cancer patients in Sweden. It references a study by E. Chandanos and colleague, published in the July 3, 2006 issue of "British Journal of Cancer." Method used in the...

  • Elderly breast cancer patients risk treatment discrimination.  // Biomedical Market Newsletter;9/30/2011, Vol. 21, p783 

    The article reports on the study which suggests that women diagnosed with breast cancer late in life are at greater risk of dying from the disease than younger patients, assuming they survive other age-related conditions.

  • United States : Bone Drugs May Not Protect Osteoporotic Women from Breast Cancer.  // TendersInfo News;8/12/2014, p1 

    The article reports on a new study led by researchers at University of California, San Francisco, which claims that osteoporosis drugs may not protect women from breast cancer as had been thought.

  • Meme Cerrahisi ve Aksiller Diseksiyon Uygulanan Meme Kanserli Hastalarda Ãœst Ekstremite Problemlerinin Sıklığı ve YaÅŸam Kalitesine Etkisi. Şimşir Atalay, Nilgün; Taflan Selçuk, Selin; Ercidoğan, Özlem; Akkaya, Nuray; Sarsan, Ayşe; Yaren, Arzu; Şahin, Füsun // Journal of Physical Medicine & Rehabilitation Sciences / Fizikse;Dec2011, Vol. 14 Issue 3/4, p186 

    Aim: The purpose of this study was to determine the prevalence of upper extremity problems in patients who had undergone breast cancer surgery, to compare the risk factors associated with these problems and to investigate their effects on quality of life. Materials and Methods: One hundred...

  • Type of breast cancer irradiation linked to risk for cardiovascular disease.  // Hem/Onc Today;12/25/2013, Vol. 14 Issue 24, p38 

    The article reports on the research conducted by David J. Brenner, Doctor of Philosophy (PhD) at the Columbia University Medical Center and his colleagues which shows that woman with breast cancer who underwent radiotherapy in a supine position has an increase risk for cardiovascular disease.

  • Established Breast Cancer Drug Increases Heart Disease Risk.  // Heart Advisor;Apr2013, Vol. 16 Issue 4, p6 

    The article discusses the findings of a study on breast cancer drug, trastuzumab (Herceptin), that may increase the risk of developing heart problems in older women. The study included more than 45,000 women, aged 67 and older, who had early-stage breast cancer. The result showed that the rates...

  • Expert opinion on the use of anthracyclines in patients with advanced breast cancer at cardiac risk. Barrett-Lee, P. J.; Dixon, J. M.; Farrell, C.; Jones, A.; Leonard, R.; Murray, N.; Palmieri, C.; Plummer, C. J.; Stanley, A.; Verrill, M. W. // Annals of Oncology;May2009, Vol. 20 Issue 5, p816 

    Anthracyclines are considered to be among the most active agents for the treatment of breast cancer. However, their use is limited by cumulative, dose-related cardiotoxicity. Such cardiotoxicity results in a permanent loss of cardiac myocytes and a progressive reduction in cardiac function...

  • Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study. Johnson, Nichola; Dudbridge, Frank; Orr, Nick; Gibson, Lorna; Jones, Michael E.; Schoemaker, Minouk J.; Folkerd, Elizabeth J.; Haynes, Ben P.; Hopper, John L.; Southey, Melissa C.; Dite, Gillian S.; Apicella, Carmel; Schmidt, Marjanka K.; Broeks, Annegien; Van't Veer, Laura J.; Atsma, Femke; Muir, Kenneth; Lophatananon, Artitaya; Fasching, Peter A.; Beckmann, Matthias W. // Breast Cancer Research;2014, Vol. 16 Issue 3, p2 

    Introduction We have previously shown that a tag single nucleotide polymorphism (rs10235235), which maps to the CYP3A locus (7q22.1), was associated with a reduction in premenopausal urinary estrone glucuronide levels and a modest reduction in risk of breast cancer in women age ⩽50 years....

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics